These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

570 related articles for article (PubMed ID: 36075472)

  • 1. Engineered extracellular vesicles: A novel platform for cancer combination therapy and cancer immunotherapy.
    Ahmadi M; Hassanpour M; Rezaie J
    Life Sci; 2022 Nov; 308():120935. PubMed ID: 36075472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineered extracellular vesicles: potentials in cancer combination therapy.
    Chen J; Tan Q; Yang Z; Jin Y
    J Nanobiotechnology; 2022 Mar; 20(1):132. PubMed ID: 35292030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineered extracellular vesicles and their mimetics for cancer immunotherapy.
    Liu C; Wang Y; Li L; He D; Chi J; Li Q; Wu Y; Zhao Y; Zhang S; Wang L; Fan Z; Liao Y
    J Control Release; 2022 Sep; 349():679-698. PubMed ID: 35878728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of engineered extracellular vesicles for targeted tumor therapy.
    Zhang F; Guo J; Zhang Z; Duan M; Wang G; Qian Y; Zhao H; Yang Z; Jiang X
    J Biomed Sci; 2022 Feb; 29(1):14. PubMed ID: 35189894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular vesicle-based therapeutics: Extracellular vesicles as therapeutic targets and agents.
    Takahashi Y; Takakura Y
    Pharmacol Ther; 2023 Feb; 242():108352. PubMed ID: 36702209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular vesicles as next generation immunotherapeutics.
    Greening DW; Xu R; Ale A; Hagemeyer CE; Chen W
    Semin Cancer Biol; 2023 May; 90():73-100. PubMed ID: 36773820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineered Extracellular Vesicles as a Targeted Delivery Platform for Precision Therapy.
    Sun Y; Sun F; Xu W; Qian H
    Tissue Eng Regen Med; 2023 Apr; 20(2):157-175. PubMed ID: 36637750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetically engineered cell-derived nanovesicles for cancer immunotherapy.
    He S; Zhao Z
    Nanoscale; 2024 May; 16(17):8317-8334. PubMed ID: 38592744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineered Extracellular Vesicles for Cancer Therapy.
    Zhang X; Zhang H; Gu J; Zhang J; Shi H; Qian H; Wang D; Xu W; Pan J; Santos HA
    Adv Mater; 2021 Apr; 33(14):e2005709. PubMed ID: 33644908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular vesicles-based drug delivery systems for cancer immunotherapy.
    Yong T; Li X; Wei Z; Gan L; Yang X
    J Control Release; 2020 Dec; 328():562-574. PubMed ID: 32946875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surface-engineered extracellular vesicles for targeted delivery of therapeutic RNAs and peptides for cancer therapy.
    Jayasinghe MK; Pirisinu M; Yang Y; Peng B; Pham TT; Lee CY; Tan M; Vu LT; Dang XT; Pham TC; Chen H; Leung AYH; Cho WC; Shi J; Le MT
    Theranostics; 2022; 12(7):3288-3315. PubMed ID: 35547755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stem cells derived extracellular vesicles: A promising nanomedicine for drug delivery system.
    Rezaie J; Nejati V; Mahmoodi M; Ahmadi M
    Biochem Pharmacol; 2022 Sep; 203():115167. PubMed ID: 35820499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Challenges and Possibilities of Extracellular Vesicles as Therapeutic Vehicles.
    Melling GE; Carollo E; Conlon R; Simpson JC; Carter DRF
    Eur J Pharm Biopharm; 2019 Nov; 144():50-56. PubMed ID: 31419585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New approaches in extracellular vesicle engineering for improving the efficacy of anti-cancer therapies.
    Jayasinghe MK; Tan M; Peng B; Yang Y; Sethi G; Pirisinu M; Le MTN
    Semin Cancer Biol; 2021 Sep; 74():62-78. PubMed ID: 33609665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular vesicles: a rising star for therapeutics and drug delivery.
    Du S; Guan Y; Xie A; Yan Z; Gao S; Li W; Rao L; Chen X; Chen T
    J Nanobiotechnology; 2023 Jul; 21(1):231. PubMed ID: 37475025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in Therapeutic Applications of Extracellular Vesicles.
    Zhang Y; Dou Y; Liu Y; Di M; Bian H; Sun X; Yang Q
    Int J Nanomedicine; 2023; 18():3285-3307. PubMed ID: 37346366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor immune escape: extracellular vesicles roles and therapeutics application.
    Ahmadi M; Abbasi R; Rezaie J
    Cell Commun Signal; 2024 Jan; 22(1):9. PubMed ID: 38167133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted therapy using engineered extracellular vesicles: principles and strategies for membrane modification.
    Liu Q; Li D; Pan X; Liang Y
    J Nanobiotechnology; 2023 Sep; 21(1):334. PubMed ID: 37717008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular vesicles remodel tumor environment for cancer immunotherapy.
    Yue M; Hu S; Sun H; Tuo B; Jia B; Chen C; Wang W; Liu J; Liu Y; Sun Z; Hu J
    Mol Cancer; 2023 Dec; 22(1):203. PubMed ID: 38087360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineered mesenchymal stem cell-derived extracellular vesicles constitute a versatile platform for targeted drug delivery.
    Meng W; Wang L; Du X; Xie M; Yang F; Li F; Wu ZE; Gan J; Wei H; Cao C; Lu S; Cao B; Li L; Li L; Zhu G
    J Control Release; 2023 Nov; 363():235-252. PubMed ID: 37739016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.